Healthcare & Life Sciences
Apex Immune
United Statesapeximmune.com
Apex Immune is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About Apex Immune
Apex Immune is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Apex Immune develops monoclonal and bispecific/multi-specific antibody-based immunotherapies targeting cancer and autoimmune diseases, focusing on enhancing immune cell function to treat patients resistant to existing therapies.
Explore Apex Immune's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.